GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Neuland Laboratories Ltd (BOM:524558) » Definitions » EV-to-Revenue

Neuland Laboratories (BOM:524558) EV-to-Revenue : 5.21 (As of May. 26, 2024)


View and export this data going back to 1994. Start your Free Trial

What is Neuland Laboratories EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Neuland Laboratories's enterprise value is ₹81,207 Mil. Neuland Laboratories's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was ₹15,586 Mil. Therefore, Neuland Laboratories's EV-to-Revenue for today is 5.21.

The historical rank and industry rank for Neuland Laboratories's EV-to-Revenue or its related term are showing as below:

BOM:524558' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.45   Med: 2.09   Max: 6.76
Current: 5.21

During the past 13 years, the highest EV-to-Revenue of Neuland Laboratories was 6.76. The lowest was 0.45. And the median was 2.09.

BOM:524558's EV-to-Revenue is ranked worse than
77.73% of 1024 companies
in the Drug Manufacturers industry
Industry Median: 2.285 vs BOM:524558: 5.21

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-26), Neuland Laboratories's stock price is ₹6348.45. Neuland Laboratories's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ₹1,214.82. Therefore, Neuland Laboratories's PS Ratio for today is 5.23.


Neuland Laboratories EV-to-Revenue Historical Data

The historical data trend for Neuland Laboratories's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neuland Laboratories EV-to-Revenue Chart

Neuland Laboratories Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.81 3.10 1.67 2.01 5.16

Neuland Laboratories Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.01 2.72 3.22 4.29 5.16

Competitive Comparison of Neuland Laboratories's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Neuland Laboratories's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Neuland Laboratories's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Neuland Laboratories's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Neuland Laboratories's EV-to-Revenue falls into.



Neuland Laboratories EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Neuland Laboratories's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=81206.972/15585.805
=5.21

Neuland Laboratories's current Enterprise Value is ₹81,207 Mil.
Neuland Laboratories's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹15,586 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Neuland Laboratories  (BOM:524558) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Neuland Laboratories's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=6348.45/1214.818
=5.23

Neuland Laboratories's share price for today is ₹6348.45.
Neuland Laboratories's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹1,214.82.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Neuland Laboratories EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Neuland Laboratories's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Neuland Laboratories (BOM:524558) Business Description

Traded in Other Exchanges
Address
Road No. 82, Jubilee Hills, Plot No. 573A-III, Phoenix IVY Building, 11th Floor (5th Office Level), Hyderabad, TG, IND, 500033
Neuland Laboratories Ltd is a manufacturer of active pharmaceutical ingredients (APIs) and an end-to-end solution provider for the pharmaceutical industry's chemistry needs in Hyderabad. Geographically, it derives a majority of revenue from North America and also has a presence in India, Europe, and Rest of the world.

Neuland Laboratories (BOM:524558) Headlines

No Headlines